Aug 2026· Neuroscience· Vol 615, pp. 299-311· 0 citations· 46 references
Medicine
TL;DR
Findings reveal separable mechanisms of action: 5-HT2A-independent, presynaptic facilitation, and 5-HT2A-dependent calcium signaling in mouse hippocampal CA1 pyramidal neurons.
Abstract
Classical psychedelics exert therapeutic effects on affective disorders, with serotonin 5-HT2A receptor activation thought to play a central role. The cellular mechanisms by which 5-HT2A signaling modulates neural circuits remain incompletely understood and may differ across mood-regulating brain regions. While psychedelic actions have been extensively studied in the medial prefrontal cortex, the hippocampus which is critical for mood, and memory has received less attention, and effects of selective 5-HT2A agonists on hippocampal neurons remain poorly characterized. Here, we examined the effects of the selective 5-HT2A agonist 25CN-NBOH on synaptic transmission, intrinsic excitability, and intracellular calcium in mouse hippocampal CA1 pyramidal neurons using whole-cell patch-clamp electrophysiology and Fura-2 AM imaging. 25CN-NBOH (10 μM) increased both spontaneous excitatory and inhibitory synaptic transmission, as indicated by elevated sEPSC and sIPSC frequency and amplitude, without affecting miniature events, suggesting action potential-dependent mechanisms. These synaptic effects persisted in the presence of the 5-HT2A antagonist MDL-100907, indicating 5-HT2A -independent synaptic facilitation. Despite increased synaptic drive, neuronal firing and action potential properties were unchanged, consistent with balanced excitation and inhibition. In contrast, 25CN-NBOH induced robust intracellular calcium elevations in CA1 neurons that were significantly reduced by MDL-100907, as well as by TTX and AMPA/NMDA receptor blockade, indicating dependence on both 5-HT2A receptor activation and glutamatergic presynaptic activity. Together, these findings reveal separable mechanisms of action: 5-HT2A-independent, presynaptic facilitation, and 5-HT2A-dependent calcium signaling. These results highlight distinct modes of hippocampal modulation by a selective 5-HT2A receptor agonist and suggest mechanisms through which psychedelics may promote plasticity-related processes.
The serotonin 2A receptor (5-HT
2A
) is a G
q/11
-coupled receptor implicated in reward processing, neuropsychiatric disorders, and the actions of serotonergic psychedelics. Although 5-HT
2A
activation has been shown to engage endocannabinoid (eCB) signaling in several brain regions, its role in inhibitory syna...
Camila Estay-Olmos, Koyam Morales-Weil, Juan Ahumada et al.· Frontiers in Pharmacology· 0 citations
Management of major depressive disorder (MDD) with conventional therapeutics that enhance monoaminergic neurotransmission requires prolonged treatment prior to clinical benefit and a substantial proportion of patients show little or no improvement. Identifying alternative molecular targets is required to develop effica...
Anna Mariano, Andrei V. Rozov, Grant D. Phillips et al.· Proceedings of the National...· 0 citations
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPA receptors) are ionotropic glutamate receptors that mediate fast excitatory neurotransmission in the central nervous system. By translating chemical signals into rapid electrical depolarization, AMPA receptors, together with NMDA and kainate receptors,...
Alessio Spinola, Maria Italia, F. Gardoni· Biomedicine & pharmacotherap...· 0 citations
Metaplastic changes driven by prenatal cannabinoid exposure (PCE) on eCB signaling at excitatory afferents on dopamine neurons are identified and include a switch in retrograde signaling favoring de novo synthesis of nitric oxide (NO) to replace the actions of eCBs, which are compromised at excitatory inputs.
Valeria Serra, F. Brandalise, Vivien Miczán et al.· bioRxiv· 0 citations
Purpose Serotonin (5-HT) release in the hippocampus is modulated by N-methyl-D-aspartate (NMDA) receptor activity, particularly under hypoxic conditions, but the roles of other neurotransmitter systems remain unclear. This study examined how several neurotransmitters affect spontaneous 5-HT release in rat hippocampal s...
Jae Heon Kim, Mi-Ho Song, Chan-Young Lee et al.· International Neurourology J...· 0 citations
INTRODUCTION
Depressive and anxiety disorders impose a substantial public health burden, yet current serotonergic therapies are limited by delayed onset, modest remission rates, and adverse side effects. Here we put forward the serotonin 1B receptor (5-HT1BR) as an important therapeutic target for mood related patholog...
Sixtine Fleury, Katherine M. Nautiyal· Expert opinion on therapeuti...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.